Intratympanic Steroid for Bell's Palsy

Clinical trial NCT03508440 · COMPLETED

Trial details

NCT number: NCT03508440
Sponsor: University of Missouri-Columbia
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Bell's Palsy Facial Nerve Paresis

Start date: 2018-01-31
Primary completion: 2022-11-22
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.